Grant
BCMA BsAb Educational Initiatives in 2L+ Relapsed/Refractory Multiple Myeloma
Pfizer
- , Add deadline: choose a calendar
- United States
- Institution applies
- Oncology, Clinical Pharmacology and
About
Independent education grants support clinicians caring for patients receiving BCMA-directed bispecific antibodies from second-line treatment of multiple myeloma onward. Programs can address safe administration, clinical decision-making and coordination between specialist and community teams.
Topics
- BCMA, search World Wide
- bispecific antibodies, search World Wide
- Multiple Myeloma, search World Wide
- Relapsed/Refractory Multiple Myeloma, search World Wide
- second-line treatment, search World Wide
- safe administration, search World Wide
- clinical decision-making, search World Wide
- Independent education grants, search World Wide
Eligibility
Covers: Up to USD 250,000 per project for one year.
The geographic scope of the call is US.
US health-profession schools, health institutions, professional societies, medical education companies and other eligible healthcare education organizations can apply. Accredited providers must meet applicable continuing education requirements.
Source: cdn.pfizer.com